# Adaptive Design Study for Safety and Efficacy of Treatment Regimens With SM-020 in Subjects With Seborrheic Keratosis

> **NCT05136144** · PHASE2 · UNKNOWN · sponsor: **DermBiont, Inc.** · enrollment: 70 (estimated)

## Conditions studied

- Seborrheic Keratosis

## Interventions

- **DRUG:** SM-020

## Key facts

- **NCT ID:** NCT05136144
- **Lead sponsor:** DermBiont, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-19
- **Primary completion:** 2024-05-31
- **Final completion:** 2024-07-31
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2023-10-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05136144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05136144, "Adaptive Design Study for Safety and Efficacy of Treatment Regimens With SM-020 in Subjects With Seborrheic Keratosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05136144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*